This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
health care | 195 |
public health | 148 |
oral health | 143 |
united states | 104 |
mental health | 99 |
periodontal disease | 90 |
systematic review | 80 |
cost per | 74 |
total cost | 70 |
dental schools | 69 |
cost overrun | 66 |
social distancing | 65 |
risk mitigation | 64 |
dental care | 64 |
economic evaluation | 62 |
clinical trials | 62 |
care costs | 60 |
psychological intervention | 59 |
cost structure | 59 |
panic spread | 57 |
pandemic influenza | 56 |
benefi ts | 56 |
psychological penalty | 55 |
infectious diseases | 53 |
school closure | 53 |
primary care | 52 |
cost savings | 52 |
temporary resettlement | 50 |
total costs | 50 |
desalination plant | 49 |
data collection | 49 |
cost data | 48 |
income countries | 47 |
average cost | 47 |
power supply | 46 |
productivity losses | 45 |
eff ectiveness | 45 |
pregnant women | 45 |
health insurance | 45 |
carbon cap | 44 |
center loss | 42 |
doc id | 42 |
palliative care | 42 |
dental education | 42 |
cord uid | 42 |
costs associated | 41 |
intervention cost | 41 |
risk factors | 40 |
infectious disease | 39 |
penalty cost | 38 |
dental insurance | 38 |
economic impact | 37 |
airline industry | 37 |
patient care | 37 |
health workers | 37 |
safe sap | 36 |
sensitive learning | 36 |
per day | 36 |
per person | 36 |
attack rate | 36 |
desalinated water | 36 |
benefit analysis | 35 |
decision making | 35 |
capacity deployment | 35 |
access hubs | 35 |
effectiveness analysis | 34 |
nai treatment | 34 |
supply chain | 34 |
present study | 34 |
planning horizon | 33 |
carbon footprint | 33 |
capacity pooling | 32 |
direct cost | 32 |
medical costs | 32 |
power law | 32 |
health services | 31 |
raw sap | 31 |
access hub | 31 |
may also | 31 |
influenza pandemic | 31 |
indirect costs | 30 |
world health | 30 |
air medical | 30 |
health outcomes | 29 |
resettlement sites | 29 |
carbon emissions | 29 |
conformance checking | 28 |
blood pressure | 28 |
per capita | 28 |
economic burden | 28 |
copyright holder | 28 |
hcv screening | 28 |
diabetes mellitus | 28 |
ic costs | 28 |
health organization | 28 |
fi ndings | 27 |
infective people | 27 |
peer review | 27 |
granted medrxiv | 27 |
respiratory infection | 27 |
indirect cost | 27 |
author funder | 27 |
infection control | 27 |
version posted | 26 |
conditional center | 26 |
per year | 26 |
digital marketing | 25 |
sensitivity analysis | 25 |
sap intervention | 25 |
ng ml | 25 |
insurance coverage | 25 |
acute respiratory | 25 |
discount rate | 24 |
transportation cost | 24 |
cost function | 24 |
least one | 24 |
cost analysis | 24 |
health authority | 24 |
electronic health | 24 |
per qaly | 24 |
economic analysis | 24 |
cost overruns | 24 |
cost effectiveness | 23 |
public service | 23 |
mitigation effort | 23 |
capacity modules | 23 |
operational cost | 23 |
developing countries | 23 |
energy consumption | 23 |
cardiovascular disease | 23 |
temporary shelters | 23 |
disease risk | 23 |
marshfi eld | 23 |
low cost | 22 |
fixed costs | 22 |
level cost | 22 |
active mobility | 22 |
air traffic | 22 |
case study | 22 |
winter games | 21 |
optimization problem | 21 |
hospitality industry | 21 |
medical care | 21 |
sap area | 21 |
shadow evacuation | 21 |
lot sizing | 21 |
signifi cant | 21 |
simulation model | 21 |
status quo | 20 |
dental coverage | 20 |
estimated cost | 20 |
budget impact | 20 |
wait times | 20 |
clinical trial | 20 |
summer games | 19 |
physical activity | 19 |
large scale | 19 |
reverse osmosis | 19 |
per annum | 19 |
medical retrievals | 19 |
qaly gained | 19 |
eff ects | 19 |
sensitivity analyses | 19 |
health economics | 19 |
additional file | 19 |
human capital | 19 |
reproduction number | 19 |
rheumatoid arthritis | 19 |
health policy | 19 |
olympic games | 19 |
losses due | 19 |
distancing interventions | 18 |
mental illness | 18 |
cost containment | 18 |
respiratory syndrome | 18 |
literature review | 18 |
vertical transmission | 18 |
opioid overdose | 18 |
antiviral treatment | 18 |
desalination plants | 18 |
health interventions | 18 |
heart failure | 18 |
national institute | 18 |
parcel logistics | 18 |
health effects | 18 |
case fatality | 18 |
deep learning | 18 |
direct medical | 18 |
related costs | 18 |
aggressive periodontitis | 18 |
fi rst | 18 |
platelet aggregation | 18 |
severity pandemics | 18 |
metabolic syndrome | 18 |
incremental cost | 18 |
storage grid | 18 |
costs per | 18 |
benefi ciaries | 18 |
adjusted life | 18 |
subsequent grief | 18 |
hospital cost | 18 |
united way | 18 |
respiratory viruses | 18 |
early readmission | 18 |
late readmissions | 17 |
controlled trial | 17 |
infl ammatory | 17 |
will also | 17 |
operating costs | 17 |
stock returns | 17 |
care system | 17 |
times higher | 17 |
marginal cost | 17 |
important role | 17 |
eld clinic | 17 |
cost matrix | 17 |
profit margin | 17 |
late readmission | 17 |
new york | 17 |
contact tracing | 17 |
healthy volunteers | 17 |
protective equipment | 17 |
information technology | 17 |
health record | 17 |
related productivity | 17 |
panic degree | 17 |
national health | 17 |
total number | 17 |
nipah virus | 17 |
healthcare costs | 17 |
hand hygiene | 16 |
human resources | 16 |
risk premium | 16 |
school closures | 16 |
health state | 16 |
societal perspective | 16 |
electricity tariffs | 16 |
private disease | 16 |
disease outbreaks | 16 |
training cost | 16 |
high severity | 16 |
disease state | 16 |
pv grid | 16 |
health system | 16 |
olympic cost | 16 |
appraisal methods | 16 |
dim techniques | 16 |
disaster victims | 16 |
early childhood | 16 |
influenza vaccination | 16 |
costs incurred | 16 |
profitable firms | 16 |
expected return | 16 |
economic evaluations | 15 |
wide range | 15 |
effective intervention | 15 |
private cost | 15 |
susceptible people | 15 |
neural networks | 15 |
interhospital transfers | 15 |
treat monitor | 15 |
chronic conditions | 15 |
oral disease | 15 |
list prices | 15 |
variable costs | 15 |
market share | 15 |
disease control | 15 |
time spent | 15 |
building cost | 15 |
grapefruit juice | 15 |
total carbon | 15 |
informal care | 15 |
care services | 15 |
urban areas | 15 |
quarantine probability | 15 |
socially optimal | 15 |
three times | 15 |
simulation modeling | 15 |
overdose deaths | 15 |
severe acute | 15 |
structure effects | 15 |
moral hazard | 15 |
traffic management | 15 |
health gains | 15 |
service announcement | 15 |
tv public | 15 |
mean cost | 15 |
coronavirus disease | 15 |
virus infection | 14 |
chronic diseases | 14 |
healthcare workers | 14 |
imported cases | 14 |
private health | 14 |
patient record | 14 |
cold product | 14 |
per cent | 14 |
highly effective | 14 |
without permission | 14 |
reuse allowed | 14 |
effectiveness ratio | 14 |
global health | 14 |
rights reserved | 14 |
quality pcc | 14 |
results indicate | 14 |
allowed without | 14 |
business model | 14 |
time away | 14 |
pilot study | 14 |
herd immunity | 14 |
cth intervention | 14 |
disaster sites | 14 |
opioid use | 14 |
electricity cost | 14 |
day course | 14 |
intervention strategies | 14 |
travel time | 14 |
care providers | 14 |
posted april | 14 |
health systems | 14 |
confidence intervals | 14 |
infl uenza | 14 |
minimum costs | 14 |
susceptible individuals | 14 |
scenario i | 14 |
remote communities | 14 |
health economic | 13 |
operating cost | 13 |
increased risk | 13 |
oral diseases | 13 |
type diabetes | 13 |
pure players | 13 |
tax rate | 13 |
nitrate excretion | 13 |
health professionals | 13 |
randomized controlled | 13 |
formal care | 13 |
time preference | 13 |
loss function | 13 |
capital investment | 13 |
ait baha | 13 |
quality measures | 13 |
pancreatic fistula | 13 |
date palm | 13 |
time series | 13 |
community contact | 13 |
economic costs | 13 |
see table | 13 |
european union | 13 |
ray images | 13 |
final cost | 13 |
supply options | 13 |
quo scenario | 13 |
resource allocation | 13 |
contact reduction | 13 |
private risk | 13 |
wave communities | 13 |
critical enablers | 13 |
national hospital | 13 |
per visit | 13 |
pv production | 13 |
illness avoidance | 13 |
low severity | 13 |
cost reduction | 13 |
centred care | 13 |
made available | 13 |
time horizon | 13 |
efficiency improvement | 13 |
cost components | 13 |
myocardial infarction | 13 |
chtouka ait | 13 |
social care | 13 |
study design | 13 |
solar electricity | 13 |
urban parcel | 13 |
pandemic scenarios | 13 |
oral cavity | 13 |
effective interventions | 13 |
shelf life | 13 |
intellectual disability | 13 |
per athlete | 13 |
high risk | 13 |
olympic costs | 13 |
clinical research | 13 |
basic reproduction | 13 |
input parameters | 13 |
healthcare system | 13 |
societal costs | 12 |
air transport | 12 |
time step | 12 |
mental disorders | 12 |
will need | 12 |
competitive advantage | 12 |
intervention costs | 12 |
capital costs | 12 |
seasonal influenza | 12 |
storage capacity | 12 |
carbon tax | 12 |
daa treatment | 12 |
results show | 12 |
overall population | 12 |
scenario ii | 12 |
heart disease | 12 |
table shows | 12 |
community containment | 12 |
policy diffusion | 12 |
posted march | 12 |
common diseases | 12 |
direct costs | 12 |
solution approach | 12 |
health authorities | 12 |
life years | 12 |
infl ammation | 12 |
training costs | 12 |
recent study | 12 |
cash flows | 12 |
association studies | 12 |
cohort study | 12 |
routing problem | 12 |
intensive care | 12 |
sample size | 12 |
palm sap | 12 |
artery disease | 12 |
improve quality | 12 |
chronic disease | 12 |
supplementary material | 12 |
implementation cost | 12 |
dental school | 12 |
nai effectiveness | 12 |
dental services | 12 |
fuel consumption | 12 |
personal protective | 12 |
childhood caries | 12 |
softmax loss | 12 |
identifi ed | 12 |
mitigation strategies | 12 |
four costs | 12 |
young children | 12 |
south africa | 12 |
restaurant industry | 12 |
passenger traffic | 12 |
policy makers | 12 |
fi nding | 12 |
modelling study | 12 |
fatality rate | 12 |
climate change | 12 |
severity categories | 12 |
best practices | 12 |
implement cth | 12 |
life care | 12 |
new zealand | 11 |
heart rate | 11 |
water cost | 11 |
market return | 11 |
may lead | 11 |
statistically significant | 11 |
air pollution | 11 |
community health | 11 |
symptom onset | 11 |
human papillomavirus | 11 |
simulation models | 11 |
healthy people | 11 |
variable cost | 11 |
clinical data | 11 |
market power | 11 |
genetic studies | 11 |
production cost | 11 |
side effects | 11 |
offi ce | 11 |
ordering policy | 11 |
risk factor | 11 |
facility location | 11 |
case isolation | 11 |
oral hygiene | 11 |
future research | 11 |
signifi cantly | 11 |
contact isolation | 11 |
eff ective | 11 |
much less | 11 |
care quality | 11 |
quality improvement | 11 |
marketing techniques | 11 |
optimal ordering | 11 |
benders decomposition | 11 |
decision makers | 11 |
law outcomes | 11 |
blood samples | 11 |
previous work | 11 |
flexible bronchoscopes | 11 |
term represents | 11 |
positive aspects | 11 |
unprofitable firms | 11 |
personal protection | 11 |
staphylococcus aureus | 11 |
hand washing | 11 |
powered desalination | 11 |
patients infected | 11 |
pandemic severity | 11 |
primary evacuations | 11 |
american dental | 11 |
communities study | 11 |
risk population | 11 |
fixed cost | 11 |
nitric oxide | 11 |
time pregnant | 11 |
inbound marketing | 11 |
modelling studies | 11 |
average electricity | 11 |
experimental results | 11 |
aviation sector | 11 |
arterial disease | 11 |
diabetes care | 11 |
risk patients | 11 |
systematic risk | 11 |
become infected | 11 |
highest cost | 11 |
dental students | 11 |
peripheral arterial | 11 |
network design | 10 |
quarantine delay | 10 |
diabetic patients | 10 |
consumer price | 10 |
renewable energy | 10 |
will use | 10 |
grained classification | 10 |
susceptible individual | 10 |
authority intervention | 10 |
respiratory infections | 10 |
influenza transmission | 10 |
capacity savings | 10 |
free rate | 10 |
hcv carriers | 10 |
respiratory tract | 10 |
reduce costs | 10 |
disaster evacuation | 10 |
online grocery | 10 |
dental profession | 10 |
conceptual framework | 10 |
social welfare | 10 |
process model | 10 |
widely used | 10 |
private dental | 10 |
vehicle routing | 10 |
private mitigation | 10 |
annual cost | 10 |
ante profitability | 10 |
search traffic | 10 |
infected people | 10 |
footprint generated | 10 |
based methods | 10 |
vaccination program | 10 |
lost productivity | 10 |
infection prevention | 10 |
total operational | 10 |
present value | 10 |
price index | 10 |
unit costs | 10 |
caregiver burden | 10 |
resistant organisms | 10 |
checking techniques | 10 |
overall cost | 10 |
adverse events | 10 |
real terms | 10 |
readmission cost | 10 |
contracting influenza | 10 |
risk groups | 10 |
prevention strategies | 10 |
care delivery | 10 |
local cell | 10 |
national grid | 10 |
optimal level | 10 |
net benefits | 10 |
costs related | 10 |
health information | 10 |
sizing policy | 10 |
health benefits | 10 |
power laws | 10 |
lowest cost | 10 |
disease management | 10 |
antiviral drugs | 10 |
lowest total | 10 |
potential cost | 10 |
room isolation | 10 |
human services | 10 |
four different | 10 |
criteria analysis | 10 |
vaccination programs | 10 |
appendix table | 10 |
capacity module | 10 |
systematic reviews | 10 |
infl uence | 10 |
minimum cost | 10 |
per averted | 10 |
grid power | 10 |
psychotic disorders | 10 |
fi nd | 10 |
solar power | 10 |
health service | 10 |
electricity prices | 10 |
integrated medical | 10 |
different power | 10 |
host cities | 10 |
continuous school | 10 |
dental benefi | 10 |
gastric emptying | 10 |
coronary artery | 10 |
averted hospitalization | 10 |
information systems | 10 |
way sensitivity | 10 |
civil aviation | 10 |
i i | 10 |
deployment strategy | 10 |
nd id | 10 |
surveillance system | 10 |
mg kg | 10 |
face masks | 10 |
pv storage | 10 |
lot size | 10 |
average costs | 10 |
home care | 10 |
reviewed articles | 10 |
intervention strategy | 10 |
optimization model | 9 |
cargo business | 9 |
three countries | 9 |
systemic health | 9 |
balance sheet | 9 |
one year | 9 |
health conditions | 9 |
solar energy | 9 |
million people | 9 |
much higher | 9 |
co emissions | 9 |
city logistics | 9 |
cost associated | 9 |
health promotion | 9 |
blue shield | 9 |
emerging markets | 9 |
infected patients | 9 |
forecasting social | 9 |
pv surface | 9 |
remote areas | 9 |
blue cross | 9 |
ponzoa technological | 9 |
hospital admission | 9 |
health records | 9 |
deep neural | 9 |
current practice | 9 |
strategic management | 9 |
social change | 9 |
solar technologies | 9 |
chest ct | 9 |
neurodevelopmental disorders | 9 |
specifi cally | 9 |
online sales | 9 |
kidney disease | 9 |
effi ciency | 9 |
starting point | 9 |
cost effective | 9 |
representative individual | 9 |
costs will | 9 |
impact diary | 9 |
way worldwide | 9 |
carbon emission | 9 |
true cost | 9 |
chronic periodontitis | 9 |
per month | 9 |
monetary cost | 9 |
three main | 9 |
craniofacial research | 9 |
marketing budget | 9 |
even though | 9 |
infected individuals | 9 |
terrorist attacks | 9 |
automated screening | 9 |
discriminative cost | 9 |
long term | 9 |
extreme values | 9 |
lower costs | 9 |
technological forecasting | 9 |
marginal costs | 9 |
lodging industry | 9 |
disease burden | 9 |
opioid crisis | 9 |
outreach facilitation | 9 |
resource utilization | 9 |
several studies | 9 |
management systems | 9 |
hospitalizations averted | 9 |
less cost | 9 |
per patient | 9 |
plasma concentrations | 9 |
deployment decisions | 9 |
market value | 9 |
significant difference | 9 |
dental treatment | 9 |
cycling projects | 9 |
fl uoride | 9 |
holding cost | 9 |
contracting strategies | 9 |
last months | 9 |
antiviral prophylaxis | 9 |
gachhi training | 9 |
outpatient visit | 9 |
per hour | 9 |
commonly used | 9 |
medicare benefi | 9 |
health problems | 9 |
delayed gastric | 9 |
belief model | 9 |
two main | 9 |
table summarizes | 9 |
substance use | 9 |
desalination unit | 9 |
cross blue | 9 |
csp storage | 9 |
total direct | 9 |
operational costs | 9 |
limited number | 9 |
san francisco | 9 |
behavior change | 9 |
operating leverage | 9 |
hcv infection | 9 |
different scenarios | 9 |
use disorder | 9 |
care cost | 9 |
four seasons | 9 |
emergency department | 9 |
small bowel | 9 |
influenza vaccine | 9 |
first stage | 9 |
carer time | 9 |
time period | 9 |
health belief | 9 |
nan doi | 9 |
health reform | 9 |
care provided | 9 |
workforce reduction | 9 |
world bank | 9 |
business plan | 9 |
explicit costs | 9 |
ff model | 9 |
relocation costs | 9 |
previous studies | 9 |
cost competitiveness | 9 |
state i | 8 |
input costs | 8 |
health center | 8 |
economic assessment | 8 |
unit operations | 8 |
event log | 8 |
postoperative complications | 8 |
dental clinic | 8 |
highly cost | 8 |
integral part | 8 |
liver disease | 8 |
health consequences | 8 |
misclassifying covid | 8 |
recourse actions | 8 |
lysine clonixinate | 8 |
large number | 8 |
search engines | 8 |
cap policy | 8 |
blood flow | 8 |
per period | 8 |
control measures | 8 |
monetary costs | 8 |
patients received | 8 |
final manuscript | 8 |
investment decisions | 8 |
may require | 8 |
facilitation intervention | 8 |
optimal strategy | 8 |
statistical analysis | 8 |
reform law | 8 |
treatment costs | 8 |
per week | 8 |
next step | 8 |
wool spots | 8 |
care needs | 8 |
highly infectious | 8 |
tactical lookahead | 8 |
lagrangian multiplier | 8 |
dental providers | 8 |
sofosbuvir daclatasvir | 8 |
revenue management | 8 |
treatment course | 8 |
grained cost | 8 |
neuraminidase inhibitors | 8 |
threshold value | 8 |
chronic periodontal | 8 |
hcs hes | 8 |
deep features | 8 |
may help | 8 |
additional costs | 8 |
capita cost | 8 |
solar irradiation | 8 |
health states | 8 |
average age | 8 |
sir model | 8 |
family physician | 8 |
health measures | 8 |
health status | 8 |
hcv prevalence | 8 |
will require | 8 |
randomized trials | 8 |
disease dynamics | 8 |
pharmaceutical interventions | 8 |
refl ux | 8 |
dental health | 8 |
year alone | 8 |
significantly higher | 8 |
health centers | 8 |
estimated using | 8 |
community based | 8 |
economic value | 8 |
dental disease | 8 |
optimal solution | 8 |
arachidonic acid | 8 |
limited health | 8 |
individual household | 8 |
blank check | 8 |
recent years | 8 |
working group | 8 |
incremental costs | 8 |
may well | 8 |
neuromotor impairment | 8 |
will provide | 8 |
associated costs | 8 |
dental visit | 8 |
wenchuan county | 8 |
dental caries | 8 |
pv electricity | 8 |
economic efficiency | 8 |
website visits | 8 |
medical school | 8 |
medical conditions | 8 |
costs include | 8 |
interventional radiology | 8 |
effectiveness analyses | 8 |
lower cost | 8 |
perishable products | 8 |
developmental medicine | 8 |
different health | 8 |
wide association | 8 |
capacity relocation | 8 |
data entry | 8 |
healing communities | 8 |
clinical management | 8 |
many countries | 8 |
integrated ehr | 8 |
air travel | 8 |
disaster site | 8 |
north america | 8 |
input data | 8 |
country risk | 8 |
asymptomatic infection | 8 |
electricity production | 8 |
two different | 8 |
treatment plan | 8 |
related health | 8 |
health sector | 8 |
cycling infrastructure | 8 |
value creation | 8 |
building shelters | 8 |
lipoic acid | 8 |
behavioral disorders | 8 |
dental record | 8 |
economic feasibility | 8 |
defi ned | 8 |
patients undergoing | 8 |
cost increases | 8 |
randomised controlled | 8 |
ehr data | 8 |
volume requirements | 8 |
corporate tax | 8 |
cotton wool | 8 |
health worker | 8 |
week intervention | 8 |
spread among | 8 |
west zone | 8 |
remaining studies | 8 |
creative commons | 8 |
influenza illnesses | 8 |
lung cancer | 8 |
convolutional neural | 8 |
high degree | 8 |
economic development | 8 |
ex vivo | 8 |
master problem | 8 |
economic performance | 8 |
homeless victims | 8 |
dental association | 8 |
holding costs | 8 |
mass gatherings | 8 |
essential health | 8 |
fuel costs | 8 |
aviation market | 8 |
initial number | 8 |
varying demand | 8 |
high cost | 8 |
pooling distance | 8 |
liver function | 8 |
health resources | 8 |
table presents | 8 |
cancer patients | 8 |
four cohorts | 8 |
respiratory disease | 8 |
fuel prices | 8 |
middle east | 8 |
vaccination programmes | 8 |
model used | 7 |
infectious individuals | 7 |
grid electricity | 7 |
annual direct | 7 |
financial distress | 7 |
open skies | 7 |
worth noting | 7 |
per unit | 7 |
center points | 7 |
least cost | 7 |
capita gdp | 7 |
intangible assets | 7 |
pandemic scenario | 7 |
rural differences | 7 |
competing interests | 7 |
last three | 7 |
different methods | 7 |
proposed solution | 7 |
coronary heart | 7 |
environmental impact | 7 |
market portfolio | 7 |
drug therapy | 7 |
household level | 7 |
van os | 7 |
operational period | 7 |
estimated costs | 7 |
short term | 7 |
change communication | 7 |
high costs | 7 |
foreign ownership | 7 |
transmission scenario | 7 |
digital environment | 7 |
epidemic control | 7 |
supply option | 7 |
scale desalination | 7 |
per kg | 7 |
less costly | 7 |
multiple constraints | 7 |
gingival enlargement | 7 |
based solution | 7 |
available data | 7 |
patient records | 7 |
first term | 7 |
treat covid | 7 |
bowel obstruction | 7 |
lagrangian relaxation | 7 |
healthy children | 7 |
economic benefits | 7 |
benefi cial | 7 |
overall health | 7 |
temporary housing | 7 |
three different | 7 |
major cities | 7 |
airline business | 7 |
transmission constant | 7 |
dependent variable | 7 |
cost related | 7 |
underlying operations | 7 |
leisure time | 7 |
care unit | 7 |
cold products | 7 |
cost incurred | 7 |
medical record | 7 |
odds ratio | 7 |
resistant staphylococcus | 7 |
early detection | 7 |
fl ow | 7 |
pv plant | 7 |
otitis media | 7 |
models will | 7 |
neural network | 7 |
first days | 7 |
less likely | 7 |
third party | 7 |
symptomatic individuals | 7 |
aggressive periodontal | 7 |
readmission diagnoses | 7 |
nursing homes | 7 |
supply side | 7 |
two studies | 7 |
us dollars | 7 |
academic literature | 7 |
infinite variance | 7 |
treat versus | 7 |
malaria control | 7 |
pregnant migrants | 7 |
clinical pharmacology | 7 |
organic nitrates | 7 |
turkish tourism | 7 |
costing items | 7 |
prevention measures | 7 |
congestion pricing | 7 |
carer burden | 7 |
health expenditure | 7 |
primary evacuation | 7 |
service provision | 7 |
intervention scenario | 7 |
electronic patient | 7 |
mmol creatinine | 7 |
acid batteries | 7 |
intellectual disabilities | 7 |
cost saving | 7 |
remote settings | 7 |
mp ti | 7 |
present paper | 7 |
mathematical models | 7 |
classification problem | 7 |
cell proliferation | 7 |
among victims | 7 |
scale screening | 7 |
path sair | 7 |
structural variants | 7 |
aged children | 7 |
single dose | 7 |
may increase | 7 |
us national | 7 |
data deviations | 7 |
effectiveness ratios | 7 |
widespread use | 7 |
levelized cost | 7 |
chronic kidney | 7 |
hospital costs | 7 |
median direct | 7 |
population genetics | 7 |
will likely | 7 |
carbon emitted | 7 |
missing data | 7 |
data constraints | 7 |
quality evidence | 7 |
deployment problem | 7 |
niv prevention | 7 |
healthy male | 7 |
economic data | 7 |
entropy loss | 7 |
saudi arabia | 7 |
case control | 7 |
controlled trials | 7 |
cost estimates | 7 |
future cash | 7 |
advertising budget | 7 |
united kingdom | 7 |
first time | 7 |
cost eff | 7 |
diffi cult | 7 |
capital approach | 7 |
opportunity costs | 7 |
older adults | 7 |
opinion leaders | 7 |
related cost | 7 |
step step | 7 |
dental informatics | 7 |
social norms | 7 |
case studies | 7 |
body weight | 7 |
conversion technology | 7 |
drug resistance | 7 |
routing cost | 7 |
dental records | 7 |
vaccination coverage | 7 |
tax policy | 7 |
attack rates | 7 |
preventive dental | 7 |
dynamic capacity | 7 |
benthamiana plants | 7 |
entire planning | 7 |
new vaccines | 7 |
factors influencing | 7 |
oral manifestations | 7 |
data sources | 7 |
national library | 7 |
care provider | 7 |
one third | 7 |
quality care | 7 |
data collected | 7 |
congestive heart | 7 |
patients will | 7 |
care programmes | 7 |
time steps | 7 |
copy number | 7 |
liver transplantation | 7 |
isolation delay | 7 |
industrialised countries | 7 |
decision tree | 7 |
infrastructure projects | 7 |
economic impacts | 7 |
nutrient solution | 7 |
general population | 7 |
service announcements | 7 |
chronic illness | 7 |
peak hours | 7 |
seawater desalination | 7 |
observation period | 7 |
one hand | 7 |
firm i | 7 |
transport policies | 7 |
risk management | 7 |
fish oil | 7 |
health plan | 7 |
studies using | 7 |
international license | 7 |
federal government | 7 |
cost advantage | 7 |
national survey | 7 |
decreased transmission | 7 |
first two | 6 |
one country | 6 |
conjugate vaccine | 6 |
american academy | 6 |
water ranges | 6 |
sensitive classification | 6 |
will occur | 6 |
urinary excretion | 6 |
royal flying | 6 |
slightly higher | 6 |
become available | 6 |
ehls will | 6 |
mast cells | 6 |
iv infusion | 6 |
selling price | 6 |
hospital admissions | 6 |
electricity generation | 6 |
clinical practice | 6 |
clinical outcome | 6 |
health needs | 6 |
take place | 6 |
pandemic preparedness | 6 |
ownership restrictions | 6 |
digital inbound | 6 |
lower respiratory | 6 |
outturn cost | 6 |
confidence interval | 6 |
mortar firms | 6 |
squamous cell | 6 |
aortic aneurysm | 6 |
western australia | 6 |
genetic association | 6 |
relatively small | 6 |
market prices | 6 |
investment costs | 6 |
human genome | 6 |
two decades | 6 |
website traffic | 6 |
restricted master | 6 |
pd complications | 6 |
fi nancial | 6 |
soluble guanylyl | 6 |
bioterrorist attack | 6 |
calculated using | 6 |
economic regulation | 6 |
flu season | 6 |
ambulatory care | 6 |
authors declare | 6 |
doctor service | 6 |
across firms | 6 |
sum function | 6 |
fatality ratio | 6 |
cost effects | 6 |
intervention implementation | 6 |
opportunity cost | 6 |
excess pv | 6 |
taking precautions | 6 |
oral microbiome | 6 |
patient safety | 6 |
cost risk | 6 |
resettlement solutions | 6 |
pipeline study | 6 |
dna variation | 6 |
average annual | 6 |
second term | 6 |
consumer prices | 6 |
cost benefit | 6 |
section presents | 6 |
within days | 6 |
tailed distributions | 6 |
study showed | 6 |
gas emissions | 6 |
seven years | 6 |
numerical results | 6 |
significant impact | 6 |
protein concentration | 6 |
location routing | 6 |
case report | 6 |
rapid systematic | 6 |
costs may | 6 |
week period | 6 |
horizontal mergers | 6 |
aggregation functions | 6 |
cost burden | 6 |
public funding | 6 |
routinely collected | 6 |
profit model | 6 |
slot allocation | 6 |
data source | 6 |
patient population | 6 |
consumer surplus | 6 |
care expenditures | 6 |
per treatment | 6 |
chronic obstructive | 6 |
pharmacokinetic parameters | 6 |
patient information | 6 |
cba may | 6 |
privately optimal | 6 |
sichuan earthquake | 6 |
longer term | 6 |
past decade | 6 |
host city | 6 |
new vaccine | 6 |
tertiary care | 6 |
uterine artery | 6 |
merging firms | 6 |
stochastic demand | 6 |
transport appraisal | 6 |
evacuation decisions | 6 |
nonpharmaceutical interventions | 6 |
opioid misuse | 6 |
cervical cancer | 6 |
flying doctor | 6 |
data capture | 6 |
improve care | 6 |
different cohorts | 6 |
outcome measures | 6 |
age groups | 6 |
psychiatric disorders | 6 |
compliance checking | 6 |
hiv aids | 6 |
significantly reduce | 6 |
nurse facilitators | 6 |
analysis shows | 6 |
ill child | 6 |
drinking raw | 6 |
first study | 6 |
legacy carriers | 6 |
special needs | 6 |
disaster areas | 6 |
empirical evidence | 6 |
results obtained | 6 |
life cycle | 6 |
stage stochastic | 6 |
economic lot | 6 |
cost option | 6 |
health research | 6 |
international health | 6 |
greenhouse gas | 6 |
future work | 6 |
electricity price | 6 |
synchronization constraint | 6 |
resistant bacteria | 6 |
joint loss | 6 |
dental home | 6 |
economic perspective | 6 |
also included | 6 |
medical cost | 6 |
surveillance networks | 6 |
like actors | 6 |
severe pandemics | 6 |
output layer | 6 |
mortality follow | 6 |
four times | 6 |
linkage disequilibrium | 6 |
iom report | 6 |
unit cost | 6 |
pandemic cost | 6 |
operating expenses | 6 |
novel coronavirus | 6 |
using data | 6 |
private sector | 6 |
developing country | 6 |
providing dental | 6 |
decision variables | 6 |
approximately billion | 6 |
intervention scenarios | 6 |
close contact | 6 |
urinary nitrate | 6 |
distancing measures | 6 |
data integration | 6 |
per dose | 6 |
commons licence | 6 |
direct health | 6 |
cell lc | 6 |
will increase | 6 |
affects psychological | 6 |
different types | 6 |
production costs | 6 |
interpersonal communication | 6 |
prevent nipah | 6 |
collected specimens | 6 |
dynamic pooled | 6 |
winter olympics | 6 |
health insurers | 6 |
competition policy | 6 |
regulatory policy | 6 |
resettlement capacity | 6 |
informal caregivers | 6 |
systemic diseases | 6 |
oral cancers | 6 |
health surveillance | 6 |
acceleration methods | 6 |
fp offices | 6 |
pediatric medical | 6 |
randomised trial | 6 |
vascular disease | 6 |
past years | 6 |
resources needed | 6 |
health emergency | 6 |
infected patient | 6 |
antiviral drug | 6 |
cost analyses | 6 |
included studies | 6 |
three scenarios | 6 |
fat tails | 6 |
may improve | 6 |
mathematical modeling | 6 |
cell carcinoma | 6 |
life satisfaction | 6 |
east zone | 6 |
energy storage | 6 |
pure player | 6 |
symptomatic infection | 6 |
hub locations | 6 |
random events | 6 |
mg per | 6 |
north zone | 6 |
major complexity | 6 |
marketing costs | 6 |
ro desalination | 6 |
impact data | 6 |
mortality rates | 6 |
among different | 6 |
fi nal | 6 |
one half | 6 |
around us | 6 |
publicly available | 6 |
costeffectiveness analysis | 6 |
aggregation operators | 6 |
pooled capacity | 6 |
operating time | 6 |
new dental | 6 |
induced platelet | 6 |
negative effects | 6 |
severity category | 6 |
new models | 6 |
medicaid dental | 6 |
economic benefi | 6 |
data will | 6 |
tactical decision | 6 |
second stage | 6 |
resettlement site | 6 |
oral administration | 6 |
randomized clinical | 6 |
economic appraisal | 6 |
among individuals | 6 |
flexible bronchoscopy | 6 |
secondary health | 6 |
marketing managers | 6 |
beginning inventory | 6 |
synovial fluid | 6 |
design problems | 6 |
prevention strategy | 6 |
scale solar | 6 |
echelon networks | 6 |
migrant women | 6 |
unsystematic risk | 6 |
transitional care | 6 |
control practices | 6 |
private individuals | 6 |
pandemic costs | 6 |
conditional information | 6 |
household income | 6 |
ml min | 6 |
merged firm | 6 |
transmission scenarios | 6 |
increased transmission | 6 |
guanylyl cyclase | 6 |
evidence suggests | 6 |
factors affecting | 6 |
diffi culty | 6 |
pandemic infl | 6 |
prices close | 6 |
six days | 6 |
informed consent | 6 |
european countries | 6 |
personal care | 6 |
cost carriers | 6 |
solar pv | 6 |
global burden | 6 |
peak prevalence | 6 |
tree model | 6 |
parameter uncertainty | 6 |
current study | 6 |
high levels | 6 |
local epidemic | 6 |
across countries | 6 |
nicotiana benthamiana | 6 |
improve efficiency | 6 |
high frequency | 6 |
electronic data | 6 |
medical retrieval | 6 |
project will | 6 |
global fund | 6 |
organ space | 6 |
detours performed | 6 |
ex ante | 6 |
deep convolutional | 5 |
dim costs | 5 |
five pandemic | 5 |
will become | 5 |
will help | 5 |
data curation | 5 |
infection within | 5 |
health security | 5 |
chronic complications | 5 |
quality control | 5 |
relevant costs | 5 |
randomised trials | 5 |
multiple data | 5 |
median indirect | 5 |
theoretical statistical | 5 |
monitor scenario | 5 |
long time | 5 |
disease surveillance | 5 |
continuous approximations | 5 |
fi eld | 5 |
process executions | 5 |
routing problems | 5 |
flyer programs | 5 |
griffithsin production | 5 |
last years | 5 |
previous study | 5 |
eradication program | 5 |
niv spillover | 5 |
policy innovations | 5 |
reviewed studies | 5 |
time varying | 5 |
country level | 5 |
reference class | 5 |
firms show | 5 |
infection rates | 5 |
general dentist | 5 |
positive individuals | 5 |
drug release | 5 |
electronic medical | 5 |
dynamic facility | 5 |
confirmed cases | 5 |
optimal alignment | 5 |
influenza virus | 5 |
medical procedures | 5 |
special health | 5 |
better understanding | 5 |
differential equations | 5 |
unit zones | 5 |
many people | 5 |
economic cost | 5 |
installed capacity | 5 |
comparative effectiveness | 5 |
entire genome | 5 |
security returns | 5 |
five years | 5 |
cost quartile | 5 |
ou i | 5 |
brand strength | 5 |
patient data | 5 |
also help | 5 |
storage activities | 5 |
fuel cost | 5 |
syndrome coronavirus | 5 |
plants per | 5 |
task force | 5 |
among pregnant | 5 |
single isolation | 5 |
water desalination | 5 |
hospitalization rate | 5 |
mg mel | 5 |
economics study | 5 |
strong convexity | 5 |
large numbers | 5 |
different stages | 5 |
external environment | 5 |
providing care | 5 |
actual cost | 5 |
pneumococcal conjugate | 5 |
day treatment | 5 |
raw date | 5 |
human serum | 5 |
lost wages | 5 |
case management | 5 |
pulmonary disease | 5 |
important factors | 5 |
care interventions | 5 |
impact analysis | 5 |
pv lcoe | 5 |
methods used | 5 |
epidemiological model | 5 |
tourism portfolio | 5 |
ex post | 5 |
physical internet | 5 |
simulation training | 5 |
public transport | 5 |
preventable disease | 5 |
different countries | 5 |
capacity utilization | 5 |
index stay | 5 |
effi cacy | 5 |
pricing policies | 5 |
long duration | 5 |
also assumed | 5 |
rate due | 5 |
peak symptomatic | 5 |
asymptomatically infectious | 5 |
drained grade | 5 |
study group | 5 |
increasing costs | 5 |
section describes | 5 |
cost changes | 5 |
spread strength | 5 |
settlement sites | 5 |
van wee | 5 |
postoperative pancreatic | 5 |
digital transformation | 5 |
surveillance systems | 5 |
critical review | 5 |
single virus | 5 |
older people | 5 |
efficiency improvements | 5 |
quality assessment | 5 |
three years | 5 |
treatment among | 5 |
complex interventions | 5 |
like pandemic | 5 |
cold supply | 5 |
market leaders | 5 |
dna methylation | 5 |
disease states | 5 |
also include | 5 |
car trips | 5 |
conducted using | 5 |
concentrating solar | 5 |
diatomaceous earth | 5 |
south zone | 5 |
hepatocellular carcinoma | 5 |
interventions will | 5 |
calendar year | 5 |
airport managers | 5 |
ownership form | 5 |
including community | 5 |
cultural change | 5 |
public policy | 5 |
saharan africa | 5 |
one week | 5 |
mitigation decisions | 5 |
emergency settlement | 5 |
high operating | 5 |
process models | 5 |
class compactness | 5 |
demonstration projects | 5 |
objective function | 5 |
collected data | 5 |
unit prices | 5 |
learning curve | 5 |
scale instances | 5 |
health classes | 5 |
influenza mitigation | 5 |
different levels | 5 |
empirical analysis | 5 |
possible way | 5 |
dental data | 5 |
medical dental | 5 |
tactical decisions | 5 |
valuation based | 5 |
hospital systems | 5 |
discrete time | 5 |
net benefit | 5 |
statistical distributions | 5 |
population groups | 5 |
gross domestic | 5 |
higher severity | 5 |
environmental impacts | 5 |
direct impact | 5 |
deaths averted | 5 |
concentrated solar | 5 |
sample sizes | 5 |
another important | 5 |
integrated care | 5 |
william gies | 5 |
viral infections | 5 |
substantially different | 5 |
driven desalination | 5 |
griffithsin per | 5 |
travel restrictions | 5 |
solar powered | 5 |
dental offi | 5 |
empirical studies | 5 |
infectious agents | 5 |
university hospital | 5 |
diff erent | 5 |
privatized airports | 5 |
four hospitals | 5 |
active travel | 5 |
related diseases | 5 |
one state | 5 |
tobacco mosaic | 5 |
waiting room | 5 |
market capitalization | 5 |
static capacity | 5 |
periodontal diseases | 5 |
family practice | 5 |
frequent flyer | 5 |
venous blood | 5 |
connected layers | 5 |
reference year | 5 |
prospective study | 5 |
regression analysis | 5 |
time periods | 5 |
urban life | 5 |
identifi es | 5 |
shadow evacuations | 5 |
based studies | 5 |
domestic product | 5 |
grocery retailers | 5 |
health offi | 5 |
fuel price | 5 |
community meetings | 5 |
complications associated | 5 |
three months | 5 |
medical technology | 5 |
rigorous social | 5 |
storage volume | 5 |
load factor | 5 |
industrialised world | 5 |
monte carlo | 5 |
risk exposure | 5 |
csp plant | 5 |
utility analysis | 5 |
care facilities | 5 |
usual activity | 5 |
economic status | 5 |
research purposes | 5 |
disease susceptibility | 5 |
lognormal distribution | 5 |
sem techniques | 5 |
healthy subjects | 5 |
downstream processing | 5 |
new infections | 5 |
death prevented | 5 |
bleeding time | 5 |
parental care | 5 |
important factor | 5 |
made pharmaceuticals | 5 |
hh strategy | 5 |
vaccine uptake | 5 |
less effective | 5 |
care may | 5 |
resettlement processes | 5 |
transport infrastructure | 5 |
glycemic control | 5 |
bicycle lanes | 5 |
external costs | 5 |
work together | 5 |
rare variants | 5 |
one case | 5 |
model will | 5 |
care units | 5 |
use disorders | 5 |
mitigation reduces | 5 |
anomaly detection | 5 |
median cost | 5 |
cap min | 5 |
data suggest | 5 |
care management | 5 |
interhospital transfer | 5 |
mena region | 5 |
total population | 5 |
urban environment | 5 |
life year | 5 |
cost estimation | 5 |
interest rates | 5 |
cost variation | 5 |
antibiotic resistance | 5 |
indication related | 5 |
based nai | 5 |
genetic technologies | 5 |
prospective analysis | 5 |
incidence rates | 5 |
far beyond | 5 |
pg ml | 5 |
medical expenditures | 5 |
different classes | 5 |
eternal beginner | 5 |
risk assessment | 5 |
financial performance | 5 |
influenza pandemics | 5 |
energy recovery | 5 |
cost reductions | 5 |
year period | 5 |
renal function | 5 |
antiviral activity | 5 |
actual costs | 5 |
household tasks | 5 |
electricity supply | 5 |
first pass | 5 |
abdominal aortic | 5 |
current state | 5 |
social costs | 5 |
radiofrequency ablation | 5 |
rolling horizon | 5 |
meaningful use | 5 |
illness rate | 5 |
higher levels | 5 |
may prove | 5 |
cost carrier | 5 |
profit margins | 5 |
effi cient | 5 |
parcel express | 5 |
administrative costs | 5 |
blood products | 5 |
male volunteers | 5 |
pv panels | 5 |
also used | 5 |
age group | 5 |
congested airports | 5 |
evidence base | 5 |
disease transmission | 5 |
onee tariffs | 5 |
economic research | 5 |
government intervention | 5 |
different approaches | 5 |
vaccine recipients | 5 |
capacity deployments | 5 |
without storage | 5 |
additional cost | 5 |
infection prevented | 5 |
law distribution | 5 |
healthcare services | 5 |
airport congestion | 5 |
optimality cuts | 5 |
good practice | 5 |
benders algorithm | 5 |
extramural rotations | 5 |
underserved patients | 5 |
costs arising | 5 |
road safety | 5 |
obstructive pulmonary | 5 |
equity capital | 5 |
threshold analysis | 5 |
power generation | 5 |
data generated | 5 |
lefevre syndrome | 5 |
total health | 5 |
optimal lot | 5 |
neighboring access | 5 |
four main | 5 |
supply alternatives | 5 |
mg i | 5 |
people will | 5 |
law enforcement | 5 |
pv power | 5 |
economic analyses | 5 |
stage variables | 5 |
airline mergers | 5 |
screening task | 5 |
years ago | 5 |
manufacturing process | 5 |
related quality | 5 |
air cargo | 5 |
osmosis desalination | 5 |
event logs | 5 |
conditions surrounding | 5 |
disaster relief | 5 |
disease avoidance | 5 |
retinal arteriolar | 5 |
last year | 5 |
mosaic virus | 5 |
online version | 5 |
sample mean | 5 |
i will | 5 |
tooth enamel | 5 |
conversion rate | 5 |
sizing problem | 5 |
specific effects | 5 |
airline market | 5 |
also likely | 5 |
near future | 5 |
care professionals | 5 |
study cost | 5 |
central database | 5 |
optimal marketing | 5 |
infectious individual | 5 |
human populations | 5 |
health history | 5 |
tmv vector | 5 |
cost bucket | 5 |
rural areas | 5 |
based costing | 5 |
neurodevelopmental disorder | 5 |
data available | 5 |
web analytics | 5 |
healthcare delivery | 5 |
airline markets | 5 |
will estimate | 5 |
market index | 5 |
costs significantly | 5 |
interglobe aviation | 5 |
effective strategy | 5 |
swine flu | 5 |
exposure prophylaxis | 5 |
allocative efficiency | 5 |
effectiveness estimates | 5 |
short duration | 5 |
different prevention | 5 |
activity levels | 5 |
controlled study | 5 |
communication intervention | 5 |
mobile production | 5 |
risk conditions | 5 |
large cost | 5 |
diffusion process | 5 |
per death | 5 |
nai regimens | 5 |
machine learning | 5 |
decide whether | 5 |
working diagnosis | 5 |
respiratory setting | 5 |
relative risk | 5 |
ordering cost | 5 |
net profit | 5 |
factors associated | 5 |
proposed approach | 5 |
urban upbringing | 5 |
new treatments | 5 |
goes beyond | 5 |
development costs | 5 |
space infection | 5 |
tract infection | 5 |
longitudinal study | 5 |
inventory models | 5 |
check syndrome | 5 |
health nurses | 5 |
primary data | 5 |
international concern | 5 |
local cells | 5 |
single country | 5 |
table app | 5 |
working paper | 5 |
education must | 5 |
submaximal exercise | 5 |
productive efficiency | 5 |
virus transmission | 5 |
based algorithm | 5 |
airline deregulation | 5 |
affinity matrix | 5 |
syndromic surveillance | 5 |
third column | 5 |
greater risk | 5 |
southern india | 5 |
management practices | 5 |
lower levels | 5 |
study designs | 5 |
infectious agent | 5 |
observational study | 5 |
stochastic program | 5 |
offi cials | 5 |
behaviour change | 5 |
pediatric care | 5 |
cerebrovascular disease | 5 |
long run | 5 |
computational performance | 5 |
market risk | 5 |
modelled community | 4 |
studies conducted | 4 |
two countries | 4 |
rst dental | 4 |
antiviral costs | 4 |
neurodevelopmental diagnosis | 4 |
next decade | 4 |
collaborative approach | 4 |
state variables | 4 |
griffithsin protein | 4 |
recovery devices | 4 |
pandemics costs | 4 |
information system | 4 |
authorized users | 4 |
respiratory illnesses | 4 |
australian institute | 4 |
remains neutral | 4 |
loss functions | 4 |
people may | 4 |
current situation | 4 |
published maps | 4 |
search engine | 4 |
obstruction requiring | 4 |
health education | 4 |
human hearts | 4 |
law distributions | 4 |
sales data | 4 |
illness costs | 4 |
optic nerve | 4 |
service network | 4 |
electricity consumed | 4 |
primary prevention | 4 |
one person | 4 |
also provide | 4 |
hypertrophic cardiomyopathy | 4 |
expected yield | 4 |
hospitality firms | 4 |
platelet function | 4 |
determine whether | 4 |
supply considered | 4 |
caries formation | 4 |
domestic markets | 4 |
art literature | 4 |
diastolic blood | 4 |
equity estimations | 4 |
cysteinyl leukotrienes | 4 |
equity estimates | 4 |
short car | 4 |
given project | 4 |
review board | 4 |
price caps | 4 |
syncytial virus | 4 |
global economy | 4 |
neuraminidase inhibitor | 4 |
viral respiratory | 4 |
catchment area | 4 |
international statistical | 4 |
class imbalance | 4 |
new entrants | 4 |
professional oral | 4 |
size premium | 4 |
traffic data | 4 |
positively related | 4 |
new score | 4 |
developing world | 4 |
association study | 4 |
immediate treatment | 4 |
natural history | 4 |
airports enjoy | 4 |
especially important | 4 |
tooth loss | 4 |
making processes | 4 |
risky behaviors | 4 |
retinal hemorrhages | 4 |
performance evaluation | 4 |
swift contact | 4 |
upstream portion | 4 |
merged firms | 4 |
productivity due | 4 |
language processing | 4 |
harvested biomass | 4 |
different sources | 4 |
low birth | 4 |
static models | 4 |
may explain | 4 |
costeff ectiveness | 4 |
periodontal treatment | 4 |
relatively high | 4 |
lower prices | 4 |
one intervention | 4 |
acinetobacter baumannii | 4 |
cost structures | 4 |
developed countries | 4 |
provide care | 4 |
care physician | 4 |
symptomatically infectious | 4 |
unprofitable firm | 4 |
primary teeth | 4 |
permanent resettlement | 4 |
visit rate | 4 |
results suggest | 4 |
person per | 4 |
multiple strategies | 4 |
total pandemic | 4 |
competitive solution | 4 |
may exist | 4 |
convolutional layers | 4 |
dental centers | 4 |
industry index | 4 |
complex diseases | 4 |
customer locations | 4 |
transport policy | 4 |
reliable data | 4 |
significant cost | 4 |
market distortions | 4 |
qualifi ed | 4 |
grocery retailing | 4 |
key model | 4 |
water supply | 4 |
duration school | 4 |
confirmed covid | 4 |
negative impact | 4 |
transportation networks | 4 |
poor oral | 4 |
lagrange multiplier | 4 |
historical data | 4 |
severe periodontitis | 4 |
practical example | 4 |
coated tablets | 4 |
emerging infectious | 4 |
reversed phase | 4 |
based cost | 4 |
small number | 4 |
particularly vulnerable | 4 |
endovascular aneurysm | 4 |
top ten | 4 |
highly variable | 4 |
overall costs | 4 |
chronic heart | 4 |
care workers | 4 |
dental examination | 4 |
dental professionals | 4 |
available operating | 4 |
healthy patients | 4 |
compartment model | 4 |
high affinity | 4 |
beginner syndrome | 4 |
new program | 4 |
respiratory syncytial | 4 |
extract solution | 4 |
misdiagnosis rate | 4 |
water tariffs | 4 |
based practices | 4 |
service delivery | 4 |
related drug | 4 |
us census | 4 |
statistically significantly | 4 |
class variations | 4 |
two types | 4 |
risk reduction | 4 |
book value | 4 |
latent period | 4 |
severity pandemic | 4 |
lease rental | 4 |
cardiac output | 4 |
exposed individuals | 4 |
industry cost | 4 |
challenges ahead | 4 |
appraisal method | 4 |
integrated record | 4 |
paper considers | 4 |
risk profile | 4 |
primary working | 4 |
incentive systems | 4 |
similar community | 4 |
paper examines | 4 |
across four | 4 |
comprehensive care | 4 |
financial incentives | 4 |
based clinics | 4 |
referral services | 4 |
urban environments | 4 |
energy cost | 4 |
narrative review | 4 |
reduces peak | 4 |
considering panic | 4 |
expression vector | 4 |
proposed discriminative | 4 |
based practice | 4 |
outcomes averted | 4 |
business models | 4 |
insurance companies | 4 |
kg fw | 4 |
scale genetic | 4 |
deep feature | 4 |
care spending | 4 |
smooth muscle | 4 |
manufacturing cost | 4 |
social networks | 4 |
core point | 4 |
scarce resource | 4 |
health emergencies | 4 |
may result | 4 |
atherosclerosis risk | 4 |
induced gingival | 4 |
cold storage | 4 |
person compared | 4 |
certain conditions | 4 |
individual will | 4 |
statistical classification | 4 |
improvement incentives | 4 |
will enable | 4 |
wood johnson | 4 |
analytical results | 4 |
pulmonary infections | 4 |
critical care | 4 |
cost efficiency | 4 |
moroccan context | 4 |
deciding whether | 4 |
comparative analysis | 4 |
true case | 4 |
avoid individuals | 4 |
production capacity | 4 |
series analysis | 4 |
communication among | 4 |
outbreak control | 4 |
cost items | 4 |
stock return | 4 |
section introduces | 4 |
many patients | 4 |
environmental externalities | 4 |
random variables | 4 |
poliovirus vaccine | 4 |
potential economic | 4 |
solar technology | 4 |
census bureau | 4 |
inclusion criteria | 4 |
equity models | 4 |
graft rejection | 4 |
environmental cleaning | 4 |
analytical framework | 4 |
optimality condition | 4 |
cycling walking | 4 |
preventive health | 4 |
firm behavior | 4 |
unemployment insurance | 4 |
study aimed | 4 |
health related | 4 |
trial data | 4 |
ro system | 4 |
higher ic | 4 |
will result | 4 |
empirical research | 4 |
useful tool | 4 |
highly pathogenic | 4 |
time needed | 4 |
data set | 4 |
us adults | 4 |
criteria decision | 4 |
lv function | 4 |
medium term | 4 |
candidate cities | 4 |
health threats | 4 |
left ventricular | 4 |
randomized trial | 4 |
vascular surgery | 4 |
death rate | 4 |
time blood | 4 |
observational studies | 4 |
artery embolisation | 4 |
drug treatment | 4 |
revenues per | 4 |
health policies | 4 |
put forward | 4 |
inoculation room | 4 |
household members | 4 |
individual countries | 4 |
coordinated care | 4 |
particular interest | 4 |
learning process | 4 |
cost trends | 4 |
related liver | 4 |
oral ulcers | 4 |
effective management | 4 |
solar panels | 4 |
study also | 4 |
mobility projects | 4 |
policy process | 4 |
gaze aversion | 4 |
research avenues | 4 |
dependent costs | 4 |
behavioral disorder | 4 |
fuzzy cost | 4 |
aqueous humor | 4 |
delivery locations | 4 |
mm hg | 4 |
distribution systems | 4 |
magnetic resonance | 4 |
large parcel | 4 |
learning approach | 4 |
nosocomial infection | 4 |
remarkably outperforms | 4 |
risk involved | 4 |
twofold increase | 4 |
population level | 4 |
reproduction numbers | 4 |
opioid epidemic | 4 |
reported cost | 4 |
community palliative | 4 |
care systems | 4 |
possible moves | 4 |
internet users | 4 |
clinical training | 4 |
cancer treatment | 4 |
reducing opioid | 4 |
influenza preparedness | 4 |
work loss | 4 |
increasing function | 4 |
brand equity | 4 |
main metabolites | 4 |
health infrastructure | 4 |
mental retardation | 4 |
computed using | 4 |
allow us | 4 |
induced psychological | 4 |
ante sanctions | 4 |
increased access | 4 |
long planning | 4 |
study child | 4 |
based study | 4 |
monopoly power | 4 |
implementation costs | 4 |
widely adopted | 4 |
single till | 4 |
medical provider | 4 |
macroeconomic variables | 4 |
griffithsin expression | 4 |
create value | 4 |
arteriolar narrowing | 4 |
coming years | 4 |
behavioral health | 4 |
productivity loss | 4 |
marketing actions | 4 |
seeking behaviour | 4 |
nai stockpile | 4 |
pcc implementation | 4 |
improved dental | 4 |
preventive care | 4 |
arthritic rats | 4 |
research study | 4 |
associated infections | 4 |
integrated electronic | 4 |
dividend growth | 4 |
baha plant | 4 |
secondary attack | 4 |
chronically infected | 4 |
dental clinics | 4 |
bisection based | 4 |
high level | 4 |
several factors | 4 |
institutional affiliations | 4 |
local hub | 4 |
hospital stays | 4 |
promising results | 4 |
heritable factors | 4 |
fuzzy sets | 4 |
tc i | 4 |
chronic illnesses | 4 |
learning model | 4 |
avoided cases | 4 |
readily available | 4 |
buying process | 4 |
table exhibits | 4 |
double counting | 4 |
data used | 4 |
although highly | 4 |
directly affects | 4 |
nature remains | 4 |
active transport | 4 |
mass production | 4 |
viral pneumonia | 4 |
five times | 4 |
computed tomography | 4 |
gene expression | 4 |
australian bureau | 4 |
cell lines | 4 |
loss group | 4 |
direct approach | 4 |
given company | 4 |
prescription drug | 4 |
rich plasma | 4 |
cost competitive | 4 |
economic theory | 4 |
positive relationship | 4 |
will include | 4 |
public sector | 4 |
underserved populations | 4 |
hotel industry | 4 |
one may | 4 |
brand value | 4 |
clinical care | 4 |
hplc method | 4 |
monoclonal antibody | 4 |
health access | 4 |
burn rate | 4 |
human resource | 4 |
service providers | 4 |
standard errors | 4 |
affected individuals | 4 |
given time | 4 |
specific risk | 4 |
null hypothesis | 4 |
avert one | 4 |
ischemic stroke | 4 |
malaria cases | 4 |
healthcare providers | 4 |
analysis cost | 4 |
aggregation operations | 4 |
specific costs | 4 |
patient compliance | 4 |
capital asset | 4 |
use flexible | 4 |
modal shift | 4 |
effectiveness acceptability | 4 |
working adults | 4 |
service utilization | 4 |
organic traffic | 4 |
dim cost | 4 |
solution algorithm | 4 |
third parties | 4 |
fresh weight | 4 |
varicella vaccination | 4 |
ill patients | 4 |
artificial intelligence | 4 |
significant reduction | 4 |
single patient | 4 |
cost recovery | 4 |
decisions made | 4 |
preventing mdros | 4 |
cycle network | 4 |
occur within | 4 |
affected people | 4 |
four strategies | 4 |
future pandemic | 4 |
enteric coated | 4 |
policy responses | 4 |
customer engagement | 4 |
costs included | 4 |
different risk | 4 |
intravenous infusion | 4 |
exorbitant cost | 4 |
grid option | 4 |
numerous studies | 4 |
expected risk | 4 |
one type | 4 |
superpro designer | 4 |
current covid | 4 |
retrospective study | 4 |
careful consideration | 4 |
failing human | 4 |
shared decision | 4 |
days post | 4 |
natural units | 4 |
airline travel | 4 |
chronic hepatitis | 4 |
jurisdictional claims | 4 |
net savings | 4 |
service quality | 4 |
service learning | 4 |
sap consumption | 4 |
transportation costs | 4 |
cluster randomized | 4 |
dental electronic | 4 |
asset pricing | 4 |
positive economic | 4 |
control program | 4 |
imperial college | 4 |
meso levels | 4 |
psychological effects | 4 |
restrict movement | 4 |
affected districts | 4 |
ehr systems | 4 |
opening date | 4 |
use bronchoscopes | 4 |
relatively low | 4 |
university hospitals | 4 |
food products | 4 |
community settings | 4 |
pandemic flu | 4 |
point estimate | 4 |
general infrastructure | 4 |
purchasing power | 4 |
certain level | 4 |
average return | 4 |
cap regulation | 4 |
study period | 4 |
vaccination may | 4 |
three groups | 4 |
gpiib llla | 4 |
cyclic gmp | 4 |
muscular blood | 4 |
online market | 4 |
will lead | 4 |
trough levels | 4 |
eff ect | 4 |
level costs | 4 |
extant literature | 4 |
intervention components | 4 |
critical revision | 4 |
available seat | 4 |
study used | 4 |
term health | 4 |
bicycle parking | 4 |
rotavirus vaccination | 4 |
published literature | 4 |
robust screening | 4 |
economic growth | 4 |
many cases | 4 |
cost effect | 4 |
bicycle share | 4 |
decision problem | 4 |
resource use | 4 |
labor cost | 4 |
workfl ow | 4 |
network planning | 4 |
next years | 4 |
diabetes federation | 4 |
related informatics | 4 |
interest rate | 4 |
school programs | 4 |
ngo staff | 4 |
health workforce | 4 |
texas revised | 4 |
free entry | 4 |
cost risks | 4 |
ante performance | 4 |
relative costs | 4 |
shelter building | 4 |
organizational culture | 4 |
key cost | 4 |
compliance level | 4 |
preschool children | 4 |
treated patients | 4 |
main difference | 4 |
deep vein | 4 |
greatest impact | 4 |
transfer learning | 4 |
medical services | 4 |
disease among | 4 |
six years | 4 |
local air | 4 |
games since | 4 |
intangible costs | 4 |
averted hospitalizations | 4 |
collection team | 4 |
optimal advertising | 4 |
integer linear | 4 |
vaccine eff | 4 |
technoeconomic modeling | 4 |
subsequent treatment | 4 |
antitrust authorities | 4 |
immunity eff | 4 |
costs required | 4 |
among children | 4 |
household prophylaxis | 4 |
hong kong | 4 |
coronary arteries | 4 |
provide dental | 4 |
optimal value | 4 |
comprehensive summary | 4 |
expecting mothers | 4 |
drinking water | 4 |
oseltamivir treatment | 4 |
first case | 4 |
electricity output | 4 |
clinical effectiveness | 4 |
oral dose | 4 |
significantly lower | 4 |
medicare prescription | 4 |
cost drivers | 4 |
two groups | 4 |
peak pricing | 4 |
major cost | 4 |
resource needs | 4 |
planning horizons | 4 |
operational efficiency | 4 |
based estimates | 4 |
higher rates | 4 |
chronic health | 4 |
significantly increased | 4 |
independent studies | 4 |
output unit | 4 |
extremely important | 4 |
economic incentives | 4 |
griffithsin manufacturing | 4 |
different interventions | 4 |
decision support | 4 |
urban mental | 4 |
uterine fibroids | 4 |
el baraka | 4 |
healthcare spending | 4 |
macy study | 4 |
prescription opioid | 4 |
month period | 4 |
information regarding | 4 |
ro plant | 4 |
percent contingency | 4 |
additional studies | 4 |
value added | 4 |
hcv treatment | 4 |
also play | 4 |
annual electricity | 4 |
increasing number | 4 |
airport infrastructure | 4 |
care plans | 4 |
api cost | 4 |
mg asa | 4 |
therapeutic changes | 4 |
healthy preschool | 4 |
exchange patient | 4 |
periodontal therapy | 4 |
suspended operations | 4 |
total emissions | 4 |
middleincome countries | 4 |